| Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial HM Prince, YH Kim, SM Horwitz, R Dummer, J Scarisbrick, P Quaglino, ... The Lancet 390 (10094), 555-566, 2017 | 556 | 2017 |
| MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy A Valera, A López-Guillermo, T Cardesa-Salzmann, F Climent, ... haematologica 98 (10), 1554, 2013 | 274 | 2013 |
| Commercial anti‐CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center P Sesques, E Ferrant, V Safar, F Wallet, J Tordo, A Dhomps, L Karlin, ... American journal of hematology 95 (11), 1324-1333, 2020 | 112 | 2020 |
| Validation of the NCCN‐IPI for diffuse large B‐cell lymphoma (DLBCL): the addition of β2‐microglobulin yields a more accurate GELTAMO‐IPI C Montalbán, A Díaz‐López, I Dlouhy, J Rovira, A Lopez‐Guillermo, ... British Journal of Haematology 176 (6), 918-928, 2017 | 97 | 2017 |
| CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survival MJ Moreno, R Bosch, R Dieguez‐Gonzalez, S Novelli, A Mozos, ... The Journal of pathology 235 (3), 445-455, 2015 | 82 | 2015 |
| Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group S Alonso‐Álvarez, L Magnano, M Alcoceba, M Andrade‐Campos, ... British journal of haematology 178 (5), 699-708, 2017 | 77 | 2017 |
| T-cell costimulatory molecules in acute-graft-versus host disease: therapeutic implications J Briones, S Novelli, J Sierra Bone marrow research 2011, 2011 | 72 | 2011 |
| Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease I García-Cadenas, I Rivera, R Martino, A Esquirol, P Barba, S Novelli, ... Bone Marrow Transplantation 52 (1), 107-113, 2017 | 62 | 2017 |
| New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta‐2 microglobulin in patients with diffuse large B‐cell lymphoma … L Bento, A Díaz‐López, G Barranco, AM Martín‐Moreno, M Baile, A Martín, ... British journal of haematology 188 (6), 888-897, 2020 | 56 | 2020 |
| Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan plus BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a … J Briones, S Novelli, JA García-Marco, JF Tomás, T Bernal, C Grande, ... haematologica 99 (3), 505, 2014 | 56 | 2014 |
| Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan plus BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a … J Briones, S Novelli, JA García-Marco, JF Tomás, T Bernal, C Grande, ... haematologica 99 (3), 505, 2014 | 56 | 2014 |
| Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab I Garcia-Cadenas, N Castillo, R Martino, P Barba, A Esquirol, S Novelli, ... Bone Marrow Transplantation 50 (4), 579-584, 2015 | 55 | 2015 |
| PET/CT assessment of follicular lymphoma and high grade B cell lymphoma–good correlation with clinical and histological features at diagnosis S Novelli, J Briones, A Flotats, J Sierra Advances in Clinical and Experimental Medicine 24 (2), 325-330, 2015 | 45 | 2015 |
| Grup per l’Estudi dels Limfomes de Catalunya i Balears (GELCAB). MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell … A Valera, A López-Guillermo, T Cardesa-Salzmann, F Climent, ... Haematologica 98 (10), 1554-1562, 2013 | 41 | 2013 |
| Autologous stem cell transplantation for follicular lymphoma: favorable long-term survival irrespective of pretransplantation rituximab exposure A Jiménez-Ubieto, C Grande, D Caballero, L Yáñez, S Novelli, ... Biology of Blood and Marrow Transplantation 23 (10), 1631-1640, 2017 | 40 | 2017 |
| Epidemiology of lymphoid malignancies: last decade update S Novelli, J Briones, J Sierra Springerplus 2, 1-4, 2013 | 40 | 2013 |
| Absolute lymphocytes, ferritin, C-reactive protein, and lactate dehydrogenase predict early invasive ventilation in patients with COVID-19 S Payán-Pernía, L Gómez Pérez, ÁF Remacha Sevilla, J Sierra Gil, ... Laboratory medicine 52 (2), 141-145, 2021 | 39 | 2021 |
| Real-life management of primary immune thrombocytopenia (ITP) in adult patients and adherence to practice guidelines ML Lozano, N Revilla, TJ Gonzalez-Lopez, S Novelli, JR González-Porras, ... Annals of Hematology 95, 1089-1098, 2016 | 39 | 2016 |
| Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population L Magnano, S Alonso‐Alvarez, M Alcoceba, A Rivas‐Delgado, ... British Journal of Haematology 185 (3), 480-491, 2019 | 36 | 2019 |
| Prognostic impact of 18F-FDG PET/CT in patients with aggressive B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T cells P Sesques, J Tordo, E Ferrant, V Safar, F Wallet, A Dhomps, G Brisou, ... Clinical nuclear medicine 46 (8), 627-634, 2021 | 30 | 2021 |
